149 related articles for article (PubMed ID: 33387886)
1. A novel long non-coding RNA PCLN16 facilitates androgen receptor signaling in prostate cancer.
Shi Z; Chen J; Wumaner A; Li M; Liang C; Li M
Biochem Biophys Res Commun; 2021 Jan; 537():78-84. PubMed ID: 33387886
[TBL] [Abstract][Full Text] [Related]
2. The long non-coding RNA PCAL7 promotes prostate cancer by strengthening androgen receptor signaling.
Li Z; Teng J; Jia Z; Zhang G; Ai X
J Clin Lab Anal; 2021 Feb; 35(2):e23645. PubMed ID: 33219721
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression.
Zhang Y; Pitchiaya S; Cieślik M; Niknafs YS; Tien JC; Hosono Y; Iyer MK; Yazdani S; Subramaniam S; Shukla SK; Jiang X; Wang L; Liu TY; Uhl M; Gawronski AR; Qiao Y; Xiao L; Dhanasekaran SM; Juckette KM; Kunju LP; Cao X; Patel U; Batish M; Shukla GC; Paulsen MT; Ljungman M; Jiang H; Mehra R; Backofen R; Sahinalp CS; Freier SM; Watt AT; Guo S; Wei JT; Feng FY; Malik R; Chinnaiyan AM
Nat Genet; 2018 Jun; 50(6):814-824. PubMed ID: 29808028
[TBL] [Abstract][Full Text] [Related]
4. Novel lncRNA
Lingadahalli S; Jadhao S; Sung YY; Chen M; Hu L; Chen X; Cheung E
Mol Cancer Res; 2018 Dec; 16(12):1865-1878. PubMed ID: 30115758
[TBL] [Abstract][Full Text] [Related]
5. Silencing of lncRNA MALAT1 inhibits cell cycle progression via androgen receptor signaling in prostate cancer cells.
Dai X; Liu L; Liang Z; Guo K; Xu S; Wang H
Pathol Res Pract; 2019 Apr; 215(4):712-721. PubMed ID: 30642743
[TBL] [Abstract][Full Text] [Related]
6. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.
Cui Z; Ren S; Lu J; Wang F; Xu W; Sun Y; Wei M; Chen J; Gao X; Xu C; Mao JH; Sun Y
Urol Oncol; 2013 Oct; 31(7):1117-23. PubMed ID: 22264502
[TBL] [Abstract][Full Text] [Related]
7. A feed-forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression.
Fang Z; Xu C; Li Y; Cai X; Ren S; Liu H; Wang Y; Wang F; Chen R; Qu M; Wang Y; Zhu Y; Zhang W; Shi X; Yao J; Gao X; Hou J; Xu C; Sun Y
Cancer Lett; 2016 Apr; 374(1):62-74. PubMed ID: 26808578
[TBL] [Abstract][Full Text] [Related]
8. LncRNA GAS5 participates in the regulation of dexamethasone on androgen receptor -negative and -positive prostate cancer cell proliferation.
Hu J; Deng J; Cao R; Xiong S; Guo J
Mol Cell Probes; 2020 Oct; 53():101607. PubMed ID: 32470500
[TBL] [Abstract][Full Text] [Related]
9. A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway.
Wang D; Wan X; Zhang Y; Kong Z; Lu Y; Sun X; Huang Y; Ji C; Li D; Luo J; Gu W; Wang C; Li Y; Xu Y
Prostate; 2019 Sep; 79(12):1362-1377. PubMed ID: 31269242
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
11. The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo.
Parolia A; Crea F; Xue H; Wang Y; Mo F; Ramnarine VR; Liu HH; Lin D; Saidy NR; Clermont PL; Cheng H; Collins C; Wang Y; Helgason CD
Mol Cancer; 2015 Feb; 14():46. PubMed ID: 25744782
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a novel long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth.
Ta HQ; Whitworth H; Yin Y; Conaway M; Frierson HF; Campbell MJ; Raj GV; Gioeli D
Mol Cancer; 2019 Jun; 18(1):113. PubMed ID: 31253147
[TBL] [Abstract][Full Text] [Related]
13. UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways.
Lacombe L; Hovington H; Brisson H; Mehdi S; Beillevaire D; Émond JP; Wagner A; Villeneuve L; Simonyan D; Ouellet V; Barrès V; Latour M; Aprikian A; Bergeron A; Castonguay V; Couture F; Chevalier S; Brimo F; Fazli L; Fleshner N; Gleave M; Karakiewicz PI; Lattouf JB; Trudel D; van der Kwast T; Mes-Masson AM; Pouliot F; Fradet Y; Audet-Walsh E; Saad F; Guillemette C; Lévesque E
Cancer Lett; 2023 Jan; 553():215994. PubMed ID: 36343786
[TBL] [Abstract][Full Text] [Related]
14. The novel long noncoding RNA LOC283070 is involved in the transition of LNCaP cells into androgen-independent cells via its interaction with PHB2.
Zhang Y; Wang LN; Lin YN; Xing YX; Shi Y; Zhao J; Chen WW; Han B
Asian J Androl; 2018; 20(5):511-517. PubMed ID: 29956684
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA GAS5 interacts and suppresses androgen receptor activity in prostate cancer cells.
Lv S; Pu X; Luo M; Wen H; Xu Z; Wei Q; Dang Q
Prostate; 2021 Sep; 81(12):893-901. PubMed ID: 34184786
[TBL] [Abstract][Full Text] [Related]
16. The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program.
Parolia A; Venalainen E; Xue H; Mather R; Lin D; Wu R; Pucci P; Rogalski J; Evans JR; Feng F; Collins CC; Wang Y; Crea F
Mol Oncol; 2019 May; 13(5):1121-1136. PubMed ID: 30776192
[TBL] [Abstract][Full Text] [Related]
17. The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer.
Larsson P; Syed Khaja AS; Semenas J; Wang T; Sarwar M; Dizeyi N; Simoulis A; Hedblom A; Wai SN; Ødum N; Persson JL
Int J Cancer; 2020 Mar; 146(6):1686-1699. PubMed ID: 31381135
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
[TBL] [Abstract][Full Text] [Related]
19. Role of lncRNAs in prostate cancer development and progression.
Weiss M; Plass C; Gerhauser C
Biol Chem; 2014 Nov; 395(11):1275-90. PubMed ID: 25153594
[TBL] [Abstract][Full Text] [Related]
20. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]